WPD Pharmaceuticals Welcome Dr. Waldemar Debinski to its Scientific Advisory Board
01 avr. 2020 03h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, April 01, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, is excited to...
Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020
30 mars 2020 06h05 HE
|
Cocrystal Pharma, Inc.
Advancing preclinical COVID-19 Coronavirus program leveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”) Continuing collaboration with Merck to discover...
Voyageur Restructures its ImagingX Joint Venture
20 mars 2020 08h00 HE
|
Voyageur Pharmaceuticals Ltd.
CALGARY, Alberta, March 20, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (the “Company” or “Voyageur”) is pleased to announce the dissolution of the current joint venture with...
WPD PHARMACEUTICALS’ WP1122 DRUG TO BE TESTED ON A RANGE OF VIRUSES INCLUDING CORONAVIRUS
19 mars 2020 03h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, announces, that its...
CENTOGENE Announces Commencement of Testing for COVID-19
18 mars 2020 14h13 HE
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Germany, March 18, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms...
WPD PHARMACEUTICALS ANNOUNCES BRAIN CANCER PATIENT FROM BERUBICIN PHASE 1 TRIAL REMAINS CANCER FREE
16 mars 2020 09h30 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, is pleased to...
WPD PHARMACEUTICALS RECEIVED $800,000 REIMBURSEMENT FROM $7.4 MILLION GOVERNMENT GRANT FOR DEVELOPMENT OF GLIOBLASTOMA DRUG
11 mars 2020 16h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, March 11, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, is pleased to...
How Best to Fix the US Healthcare System? For Physicians, It Starts with Affordability and Access, Says InCrowd Data
27 févr. 2020 11h00 HE
|
InCrowd, Inc
WATERTOWN, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) -- As healthcare reform dominates political discourse, those who know the US healthcare market perhaps best—US physicians—reported significantly...
Phathom Pharmaceuticals to Present at 40th Annual Cowen and Company Health Care Conference on March 2, 2020
25 févr. 2020 16h35 HE
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
WPD Pharmaceuticals Granted Key Patent Exclusively Licensed From Wake Forest University
24 févr. 2020 03h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia , Feb. 24, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to...